SLC7A11 and amyotrophic lateral sclerosis: Surprisingly, the deletion of xCT/Slc7a11 in mutated SOD1G37R ALS mice anticipated the onset but significantly slowed down the progression of the disease, consistent with the dual role of microglia and glutamate’s downstream effects during disease progression [288].